Highlights:
- Major news from the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), including first-time data presentations on the DISTAL, ESCAPE-MeVO and DISCOUNT trials evaluating mechanical thrombectomy in distal/medium-vessel occlusion stroke
- Coverage of results from the MEMBRANE and RESCUE-ICAS studies presented at last year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA), in addition to highlights from other late-2024 meetings including the World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates) and the BRAIN conference (2–4 December, London, UK)
- An exclusive interview with Basking Biosciences co-founder Shahid Nimjee (Columbus, USA) regarding the potential impact of a reversible thrombolytic drug on ischaemic stroke care
- PROFILE: Simona Sacco (L’Aquila, Italy)
- CAROTID: A closer look at the latest ROADSTER 3 findings assessing transcarotid artery revascularisation (TCAR), discussions of endovascular brain procedures being the ‘next frontier’ for vascular surgery, and more
